In ZS’s survey of Canadian pharmaceutical companies, we uncovered their plans to more fully use patient support program data, real-world evidence and artificial intelligence/advanced analytics to help improve health outcomes. Here’s a look at the initiatives they plan to implement in the next 24 months.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
